{"id":"https://openalex.org/W2091595086","doi":"https://doi.org/10.1097/00004850-199300840-00015","title":"Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine","display_name":"Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine","alternate_titles":[],"publication_year":1993,"publication_date":"1993-01-01","ids":{"openalex":"https://openalex.org/W2091595086","doi":"https://doi.org/10.1097/00004850-199300840-00015","mag":"2091595086","pmid":"https://pubmed.ncbi.nlm.nih.gov/8277151"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199300840-00015","doi":"https://doi.org/10.1097/00004850-199300840-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300840-00015","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2091595086"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"A. Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Wood","raw_affiliation_strings":["Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, UK","1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, UK","institution_ids":[]},{"raw_affiliation_string":"1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","institution_ids":[]},{"raw_affiliation_string":"2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109214489","display_name":"Gary D. Tollefson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. D. Tollefson","raw_affiliation_strings":["1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","institution_ids":[]},{"raw_affiliation_string":"2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074883362","display_name":"Martin A. Birkett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Birkett","raw_affiliation_strings":["1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK","institution_ids":[]},{"raw_affiliation_string":"2Psychopharmacology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"3Statistician, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":2.2234,"has_fulltext":false,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.86251088,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"8","issue":"4","first_page":"301","last_page":"306"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.7850000262260437},{"id":"https://openalex.org/keywords/serotonergic-neurotransmission","display_name":"serotonergic neurotransmission","score":0.9300000071525574},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6190000176429749},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5350000262260437},{"id":"https://openalex.org/keywords/treatment-withdrawal","display_name":"treatment withdrawal","score":0.43799999356269836},{"id":"https://openalex.org/keywords/long-term-treatment-response","display_name":"long-term treatment response","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.9111809730529785},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.7349557876586914},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.5827934145927429},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.4656885862350464},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43590080738067627},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.42861640453338623},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38475683331489563},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1961376667022705},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.06021296977996826},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008134","descriptor_name":"Long-Term Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199300840-00015","doi":"https://doi.org/10.1097/00004850-199300840-00015","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199300840-00015","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:8277151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8277151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066699849","https://openalex.org/W1987190509","https://openalex.org/W2012040360","https://openalex.org/W2400010629","https://openalex.org/W2414490890","https://openalex.org/W2044098244","https://openalex.org/W13900298","https://openalex.org/W2412595961","https://openalex.org/W2428398408","https://openalex.org/W2160415283"],"abstract_inverted_index":{"Recent":[0],"epidemiological":[1],"data":[2,49,78],"have":[3,23,60],"shown":[4,124],"that":[5,80],"obsessive":[6],"compulsive":[7],"disorder":[8],"(OCD)":[9],"has":[10,34,122],"a":[11,25,65],"lifetime":[12],"prevalence":[13],"of":[14,45,56,64,118,130,133,151],"2.5-3.0%.":[15],"Compounds":[16],"having":[17],"an":[18,107,139],"effect":[19,28,69],"on":[20,37],"serotonergic":[21],"neurotransmission":[22],"demonstrated":[24,61],"reproducible":[26],"therapeutic":[27,68,91],"in":[29,70,87,104,138,148],"OCD.":[30,73],"Most":[31],"recent":[32],"attention":[33],"been":[35,123],"focused":[36],"the":[38,57],"specific":[39],"serotonin":[40],"re-uptake":[41],"inhibitor":[42],"(SSRI)":[43],"class":[44],"compounds.":[46],"The":[47,90],"pooled":[48],"from":[50,99],"two":[51],"recently":[52],"completed":[53],"placebo-controlled":[54],"studies":[55,101],"SSRI,":[58],"fluoxetine,":[59,81],"clear":[62],"evidence":[63],"clinically":[66],"valuable":[67],"patients":[71],"with":[72,114],"Combined":[74],"efficacy":[75],"and":[76,95,135,145],"safety":[77],"suggest":[79,102],"20":[82],"mg/day,":[83],"will":[84],"be":[85,112,126],"effective":[86],"many":[88],"patients.":[89,152],"response":[92,109,121],"emerges":[93],"slowly":[94],"increases":[96],"gradually.":[97],"Data":[98],"extension":[100],"that,":[103],"some":[105],"patients,":[106],"optimal":[108],"may":[110],"only":[111],"achieved":[113],"higher":[115],"daily":[116],"doses":[117],"fluoxetine.":[119],"Clinical":[120],"to":[125],"sustained":[127],"over":[128],"periods":[129],"9":[131],"months":[132],"treatment":[134],"following":[136],"withdrawal":[137],"open-label":[140],"trial.":[141],"Fluoxetine":[142],"is":[143],"safe":[144],"well":[146],"tolerated":[147],"this":[149],"group":[150]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2091595086","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
